GRM7 and phobic disorder: The specific targeting of activated glutamatergic synapses following recall may make negative allosteric modulators of mGlu7 ideal compounds to apply following fear memory recall during psychiatric interventions in the future, when patients relive the traumatic event, or are exposed to a frightening situation to recall phobia.